TMO Thermo Fisher Scientific
- Official Name: THERMO FISHER SCIENTIFIC INCORPORATED
- Headquarters: 168 Third Avenue, WALTHAM, MA, 02451 US
- CEO: Marc N. Casper
- Website: thermofisher.com
Match Results
| Date | League | Week | Opponent | Result | Score |
|---|---|---|---|---|---|
| 2025-07-15 | 1 | Won by 3.377 | (1.692) - (5.069) | ||
| 2025-07-22 | 2 | Won by 4.182 | 1.822 - (2.360) | ||
| 2025-07-29 | 3 | Won by 16.900 TOTW | 14.057 - (2.843) | ||
| 2025-07-29 | 2R | Won by 0.134 | (0.558) - (0.692) | ||
| 2025-08-05 | 4 | Lost by 2.306 | (2.664) - (0.358) | ||
| 2025-08-06 | 1R | Lost by 2.339 | (3.413) - (1.074) | ||
| 2025-08-07 | 1R | Won by 1.697 | 0.979 - (0.718) | ||
| 2025-08-12 | 5 | Won by 0.717 | 2.846 - 2.129 | ||
| 2025-08-12 | 3R | Won by 3.082 | 2.783 - (0.299) | ||
| 2025-08-19 | 6 | Won by 4.297 | 4.229 - (0.068) | ||
| 2025-08-21 | 2R | Lost by 1.316 | (1.856) - (0.540) | ||
| 2025-08-26 | 7 | Lost by 4.213 | (2.065) - 2.148 | ||
| 2025-08-26 | 4R | Lost by 0.108 | (0.463) - (0.355) | ||
| 2025-09-02 | 8 | Lost by 1.598 | (0.241) - 1.357 | ||
| 2025-09-09 | 9 | Lost by 1.154 | (1.211) - (0.057) | ||
| 2025-09-16 | 10 | Lost by 2.523 | (0.347) - 2.176 | ||
| 2025-09-23 | 11 | Lost by 6.907 | (2.196) - 4.711 | ||
| 2025-09-30 | 12 | Won by 0.512 | 2.884 - 2.372 | ||
| 2025-10-07 | 13 | Won by 4.322 TOTW | 7.909 - 3.587 | ||
| 2025-10-14 | 14 | Lost by 4.003 | (2.419) - 1.584 | ||
| 2025-10-21 | 15 | Won by 7.540 TOTW | 5.934 - (1.606) |
Latest News

Thermo Fisher Scientific (TMO) Is Building A Bigger Role In Precision Diagnostics
Thermo Fisher Scientific (NYSE:TMO) is expanding its presence in proteomic biomarker analytics and immuno-oncology diagnostics, according to recent in...

Thermo Fisher Scientific (TMO) Stock Gets Fair Value Bump After Q2 Driven Analyst Target Increases
Thermo Fisher Scientific’s fair value estimate has shifted from US$652.85 to US$686.64, pointing to a modestly higher price target in current models...

Coca-Cola, Visa and Mastercard Hit Records as Investors Rotate Out of Chip Stocks
Coca-Cola, Visa and Mastercard are among the stocks hitting records as investors look beyond the AI trade. Earnings could help broaden the rally.

Learn Why The Bull Case For Thermo Fisher Scientific Stock Could Change Following Omics Demand Growth
Quantum BioPharma previously announced a Study Start-Up Agreement with Thermo Fisher Scientific’s clinical research business for a Phase 2 Lucid-MS ...

Thermo Fisher Scientific Outperforms on Strong Results and Life Sciences Recovery
Diamond Hill Capital, a First Eagle Investment Management company, issued its Q3 2026 investor letter for its “Large Cap Strategy”. The letter can...

Lam Research Could Swing $28.6 Billion After Earnings
Discover 9 stocks with the biggest options-implied earnings moves, led by Spotify at 9.31%, as investors prepare for key quarterly results.

Academic and Government Spending Powers Thermo Fisher (TMO)
Emerald Wealth Partners, an independent asset and wealth management firm based in Zurich, released its Q3 2026 investor letter for the “Focused Equi...

What Analyst Projections for Key Metrics Reveal About Thermo Fisher (TMO) Q3 Earnings
Besides Wall Street's top-and-bottom-line estimates for Thermo Fisher (TMO), review projections for some of its key metrics to gain a deeper unde...

If You Invested $1000 in Thermo Fisher Scientific a Decade Ago, This is How Much It'd Be Worth Now
Why investing for the long run, especially if you buy certain popular stocks, could reap huge rewards.

Immuno-Oncology Diagnostics Market to Reach $11.1B by 2030 as Checkpoint Inhibitor and Cell Therapy Pipelines Drive Demand for Companion Tests
Report Tracks Roche Diagnostics, Thermo Fisher, Illumina, Agilent and Guardant Health Among 132 Companies, With Forecasts by Assay Type, Technology, C...

Global Proteomic Biomarker Analytics Market: Five-Year Forecast by Application, Technology, Product, and End User | Double-Digit Growth Boosts Cancer Diagnostics and Drug Discovery
New 307-page intelligence report maps surging demand for targeted omics technologies, profiling strategic moves by Danaher, Roche, and Thermo Fisher S...

Thermo Fisher: Strong Growth, Even Higher Stock Price
Thermo Fisher Scientific remains overvalued despite strong Q2/26 results and a 30% stock rally since the last review. I rate the TMO stock a Hold. Rea...

Gilead and Cardinal Health Stocks Jump to Record Highs. Why Healthcare Is on a Tear.
AbbVie, meanwhile, closed just shy of a record high, with shares ticking up 0.6% to $283.40.

Pfizer, Thermo Fisher Scientific And More: CNBC’s ‘Final Trades’
CNBC Final Trades: Weiss picked 10-year Treasuries, Thomas chose XAR, Firestone favored TMO, and Terranova selected PFE.

How To Invest In AI Drug Discovery
While AI can design prospective drug molecules in seconds, validating whether they work still depends on slow physical wet-lab testing and custom test...

Quantum BioPharma’s Phase 2 Shows Where Biotech Value Actually Gets Built
Biotech stocks trade on FDA trial phases. Phase 2 data often builds value, cash runway limits dilution, and Quantum BioPharma just began a phase 2 MS ...

Final Trades: Thermo Fisher, Pfizer, U.S. 10-year and the XAR
The Investment Committee gives you their top stocks to watch for the second half.

Thermo Fisher Scientific (TMO) Reports Next Week: Wall Street Expects Earnings Growth
Thermo Fisher (TMO) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepa...

Is Adlai Nortye Ltd. Sponsored ADR (ANL) Stock Outpacing Its Medical Peers This Year?
Here is how Adlai Nortye Ltd. Sponsored ADR (ANL) and Thermo Fisher Scientific (TMO) have performed compared to their sector so far this year.

Single-Use Assemblies Global Market Report 2026-2030 | Capitalize on 22.8% CAGR as Thermo Fisher, Danaher, Sartorius, Merck, and Avantor Scale Modular Bioprocessing
Boost ROI with modular, customized systems that scale flexibly, cut cleaning and contamination costs, speed fill-finish, and localize sourcing to redu...

Global 3D Cell Culture Technologies Market Report 2026-2030 | Capitalize on 19.9% CAGR as Merck KGaA, Corning, Thermo Fisher Scientific, Sartorius, and Lonza Scale Organoids
Boost ROI with scalable, high-throughput 3D platforms that cut variability and per-sample costs, maximize limited cells, and localize production to of...

Global Metabolomics Market Report 2026: Size, Trends, and Forecast to 2030 | Capitalize on 17.3% CAGR as Thermo Fisher, Bruker, Agilent, and Metabolon Accelerate AI Diagnostics
Players: Metabolon, Bruker, Agilent, Thermo Fisher and Waters. Profiles cover products, services, market share, segments, trends, opportunities and re...

Global Flow Cytometry Market Report 2026 | Capitalize on 11.3% CAGR as Beckman Coulter, Thermo Fisher, Cytek, and Bio-Rad Scale AI Automation and Precision Medicine
Boost ROI through automated sample prep, AI analytics, high-throughput testing, portfolio expansion via acquisitions, and regional production to reduc...

Biophotonics Market Report 2026: Size, Share, Trends, and Forecast to 2030 | Capitalize on AI Imaging and Precision Diagnostics with Thermo Fisher, Philips, ZEISS, and Olympus
Players: Thermo Fisher, IPG Photonics, HORIBA, Roche and Olympus. Profiles cover biophotonics products, market share, segments, trends and opportuniti...

Global Cell Culture Consumables and Equipment Market Report 2026 | Capitalize on Automation and Cell Therapy as Thermo Fisher, Danaher, Sartorius and Corning Target $25.49B by 2030
Boost ROI via automation, contamination control, premium consumables, targeted R&D, strategic acquisitions and localized manufacturing to offset t...

Biotech and Pharma Rebound Strengthen Thermo’s (TMO) Organic Growth
Lindsell Train Ltd, an investment management company, has released its “Lindsell Train Global Equity Fund” third-quarter 2026 investor letter. The...

10 Health Care Stocks With Whale Alerts In Today’s Session
This whale alert can help traders discover the next big trading opportunities. Whales are entities with large sums of money and we track their transac...

Thermo Fisher to Report Q3 Earnings: What's in the Cards?
TMO gears up for Q3 earnings, with revenue and EPS growth expected amid strong bioproduction demand, product innovations and clinical research strengt...
Morgan Stanley Maintains Overweight on Thermo Fisher Scientific, Raises Price Target to $730
Morgan Stanley analyst Tejas Savant maintains Thermo Fisher Scientific (NYSE:TMO) with a Overweight and raises the price target from $650 to $730.

Thermo Fisher’s Expanded Drug Lifecycle Role Might Change The Case For Investing In Thermo Fisher Scientific (TMO)
Earlier this month, Quantum BioPharma announced a Study Start-Up Agreement with Thermo Fisher Scientific’s clinical research business to implement a...

Should You Add Abbott Stock to Your Portfolio Ahead of Q3 Earnings?
ABT's Q3 earnings are likely to have benefited from Diagnostics growth, Medical Device momentum and Nutrition innovations, while its valuation be...
TD Cowen Maintains Buy on Thermo Fisher Scientific, Raises Price Target to $760
TD Cowen analyst Dan Brennan maintains Thermo Fisher Scientific (NYSE:TMO) with a Buy and raises the price target from $675 to $760.

Thermo Fisher (TMO) Stock Trades Near Fair Value On Digital CMC Launch
Thermo Fisher Scientific has delivered a solid share price run in recent years, which puts a spotlight on whether the current US$662.24 level lines up...

Global Cell Culture Market Report 2026: Size, Share, Trends and Forecast to 2030 | Capitalize on Biologics and Personalized Medicine with Thermo Fisher, Merck, Lonza and Sartorius
Dublin, Oct. 13, 2026 (GLOBE NEWSWIRE) -- "Cell Culture Market Report 2026" has been added to ResearchAndMarkets.com's offering. The gl...

Global Protein Labeling Market Report 2026: Size, Share, Trends, and 2030 Forecast | Capture a $4.89 Billion Market as Thermo Fisher, Merck, Bio-Rad, and Abcam Scale Automation
Dublin, Oct. 13, 2026 (GLOBE NEWSWIRE) -- "Protein Labeling Market Report 2026" has been added to ResearchAndMarkets.com's offering. Th...

Continuous Bioprocessing Market 2026: Global Size, Share, Trends, and Forecast to 2030 | Capitalize on 21.5% CAGR with Thermo Fisher, Danaher, Merck KGaA, Sartorius, and Lonza
Dublin, Oct. 13, 2026 (GLOBE NEWSWIRE) -- "Continuous Bioprocessing Market Global Report 2026" has been added to ResearchAndMarkets.com'...

Global Industrial Bioprocessing Market Report 2026: Size, Share, Trends and Forecast to 2030 | Capitalize on 9% CAGR with Thermo Fisher, Danaher, Merck and Sartorius
Boost ROI via partnerships, process intensification, single-use systems, modular bioreactors, efficient purification and capacity expansionDublin, Oct...

Global Bioprocessing Monitoring Market Report 2026 | Capitalize on $18.63B by 2030 as Thermo Fisher, Danaher, Sartorius and Repligen Accelerate Real-Time PAT
Dublin, Oct. 13, 2026 (GLOBE NEWSWIRE) -- "Bioprocessing Monitoring Market Global Report 2026" has been added to ResearchAndMarkets.com'...

Global Bioprocessing Supplies Market Report 2026: Size, Share, Trends, and Forecast to 2030 | Capitalize on Single-Use Scale with Thermo Fisher, Danaher, Merck, Sartorius
Dublin, Oct. 13, 2026 (GLOBE NEWSWIRE) -- "Bioprocessing Supplies Market Global Report 2026" has been added to ResearchAndMarkets.com's...

Global Chromosomal Microarray Reflex Testing Market Report 2026-2030 | Capitalize on 9.1% CAGR as Thermo Fisher, LabCorp, Illumina, Agilent, and Natera Scale Precision Genomics
Dublin, Oct. 13, 2026 (GLOBE NEWSWIRE) -- "Chromosomal Microarray Reflex Testing Global Market Report 2026" has been added to ResearchAndMar...

Magneto-Deoxyribonucleic Acid (DNA) Biosensors Global Market Report 2026 | Capitalize on 12.9% CAGR and AI Diagnostics with Roche, Thermo Fisher, Siemens Healthineers and Danaher
Magneto-DNA Biosensors Market Set to Reach $2.66 Billion by 2030 as Precision Diagnostics AdvanceDublin, Oct. 13, 2026 (GLOBE NEWSWIRE) -- "Magne...

Global Bioconjugation Reagents Market Report 2026: Size, Trends, and Forecast to 2030 | Accelerate ADC and Click Chemistry Growth with Thermo Fisher, Merck, Danaher, and Bio-Rad
Bioconjugation Reagents Market to Reach $3.87 Billion by 2030 as Precision Medicine and Antibody-Drug Conjugate Demand ExpandsDublin, Oct. 13, 2026 (G...